[Skip to Navigation]
Sign In
May 3, 2021

Error in Discussion

JAMA Neurol. 2021;78(6):765. doi:10.1001/jamaneurol.2021.1236

In the Original Investigation “Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients With Multiple Sclerosis,”1 there was an error in the Discussion. The mortality rate in the COViMS Registry (3.3%) is higher, rather than lower, than the US mortality rate (1.8%). This article was corrected online.

Salter  A, Fox  RJ, Newsome  SD,  et al.  Outcomes and risk factors associated with SARS-CoV-2 infection in a North American registry of patients with multiple sclerosis.   JAMA Neurol. 2021. doi:10.1001/jamaneurol.2021.0688PubMedGoogle Scholar